ClinicalTrials.Veeva

Menu

Epigenetic Modifications of Diabetes Mellitus Type I

S

Scripps Translational Science Institute

Status

Withdrawn

Conditions

Type I Diabetes

Treatments

Procedure: Oral glucose tolerance test for Phase I

Study type

Observational

Funder types

Other

Identifiers

NCT01623388
11-5649

Details and patient eligibility

About

This research is being done to find out if significant changes in blood glucose cause bad outcomes in patients with diabetes.

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-65 years old
  • Diagnosis of Type I diabetes
  • Willing to wear continuous blood glucose monitor as specified in protocol

Exclusion criteria

  • Pregnant or planning to become pregnant during the study

Healthy control group Inclusion:

  • 18-65 years old
  • Willing to wear continuous blood glucose monitor as specified in protocol

Exclusion:

  • Pregnant or planning to become pregnant during the study
  • Diagnosis of Type I or II Diabetes

Trial design

0 participants in 1 patient group

Phase I
Treatment:
Procedure: Oral glucose tolerance test for Phase I

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems